Related Experiment Videos
B cells and autoimmune liver diseases
Yuki Moritoki1, Zhe-Xiong Lian, Yoshiyuki Ohsugi
1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 E. Health Sciences Drive, Suite 6510, Davis, CA 95616, USA.
Autoimmunity Reviews
|August 22, 2006
Summary
This review details the serological features of autoimmune liver diseases like autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). It explores the roles of autoreactive B cells, toll-like receptor signaling, and regulatory T cell defects in their development.
Area of Science:
- Hepatology
- Immunology
Background:
- Autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) are major autoimmune liver diseases.
- These conditions share common autoantibodies, with some specific to individual diseases.
Purpose of the Study:
- To review the serological characteristics of AIH, PBC, and PSC.
- To highlight the pathogenic roles of autoreactive B cells and toll-like receptor (TLR) signaling.
- To discuss the contribution of regulatory T cell defects in autoimmune liver disease development.
Main Methods:
- Literature review focusing on serological features and immunological mechanisms.
- Analysis of autoantibody profiles across AIH, PBC, and PSC.
- Examination of B cell and T cell functions in autoimmune liver disease pathogenesis.
Main Results:
- Detailed serological profiles for AIH, PBC, and PSC are presented.
- Autoreactive B cells function as autoantibody producers and antigen-presenting cells.
- TLR signaling contributes to autoimmune B cell activation.
Conclusions:
- Understanding autoantibody specificities is crucial for diagnosing autoimmune liver diseases.
- Autoreactive B cells, TLR signaling, and regulatory T cell dysfunction are key players in AIH, PBC, and PSC pathogenesis.